Search Results - "May, Shoshanna"
-
1
Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform
Published in Journal of clinical virology (01-06-2020)“…•Antiretroviral drug resistance testing now routine in patients infected with HIV•Traditional Sanger sequencing may miss drug resistant minority viral…”
Get full text
Journal Article -
2
Comparative evaluation of 2 automated molecular systems for the detection of HSV-1 and 2 from genital swab specimens
Published in Diagnostic microbiology and infectious disease (01-01-2019)“…BD ProbeTec HSV 1 & 2 Qx (on the BD Viper XTR) and the Aptima HSV 1 & 2 (on the Hologic Panther) assays were compared. Of 257 clinical samples, 96.6% positive…”
Get full text
Journal Article -
3
Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays
Published in Journal of clinical virology (01-09-2018)“…•HIV, HBV, HCV viral load testing is important for monitoring response to therapy.•Multiple semi-automated platforms and assays are available that can save…”
Get full text
Journal Article -
4
Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic
Published in The Journal of infection (01-10-2020)Get full text
Journal Article -
5
Xpert Xpress Flu/RSV: Validation and impact evaluation at a large UK hospital trust
Published in Journal of medical virology (01-08-2021)“…Despite vaccination programs and antivirals, influenza remains a prominent cause of morbidity and mortality. The Xpert Xpress Flu/respiratory syncytial virus…”
Get full text
Journal Article -
6
Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales
Published in The Journal of infectious diseases (24-07-2018)“…It is believed that between 2% and 5% of infants born to hepatitis B virus (HBV)-infected mothers at a high risk of perinatal transmission will become…”
Get full text
Journal Article -
7
Poor transmission of seasonal cold viruses in a British Antarctic Survey base
Published in The Journal of infection (01-06-2019)Get full text
Journal Article -
8
Comparative hepatitis C genotype 1–3 viral load kinetics in response to directly-acting antiviral therapy
Published in The Journal of infection (01-05-2020)Get full text
Journal Article -
9
Molecular epidemiology of newly acquired hepatitis C infections in England 2008–2011: Genotype, phylogeny and mutation analysis
Published in Journal of clinical virology (01-03-2015)“…Highlights • Molecular epidemiology of newly acquired hepatitis C infections in England. • Evidence for the transmission of NS3 mutations associated with…”
Get full text
Journal Article -
10
Understanding immunisation failure of neonatal HBV prevention: Presentation at ESCV 2015: Oral 23
Published in Journal of clinical virology (01-09-2015)Get full text
Journal Article -
11
Understanding immunisation failure of neonatal HBV prevention
Published in Journal of clinical virology (01-09-2015)Get full text
Journal Article -
12
Recent introduction or ancient ancestry? Use of genetic evidence to investigate the origins of range edge populations in natterjack toads (Bufo calamita)
Published in Conservation genetics (01-02-2010)“…The ability to distinguish between native and translocated populations is important in conservation biology, but can be problematic, especially near range…”
Get full text
Journal Article -
13
Fitness and genetic diversity in bufo calamita populations
Published 01-01-2009“…The aims of this DPhil were the characterisation of major histocompatibility complex class II β loci in the amphibian species Bufo calamita, determination of…”
Get full text
Dissertation -
14
Comparison of Clinical Characteristics of Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Versus Those Who Fully Responded
Published in Journal of neurogastroenterology and motility (30-10-2011)“…Background/Aims Refractory gastroesophageal reflux disease (GERD) is very common, affecting up to 40% of the patients receiving proton pump inhibitor (PPI)…”
Get full text
Journal Article